Catalyst Event

Viatris Inc (VTRS) · Other

From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)

3/23/2026, 12:00:00 AM

OtherSentiment: Positive

Viatris announced on March 23, 2026, that Japan's Ministry of Health, Labour and Welfare (MHLW) approved Effexor® SR capsules for the treatment of adults with generalized anxiety disorder (GAD), making it the first and only approved treatment for GAD in Japan.

Korean Translation

Viatris는 2026년 3월 23일, 일본 후생노동성(MHLW)이 성인 범불안장애(GAD) 치료를 위한 Effexor® SR 캡슐을 승인했다고 발표함. 이는 일본에서 GAD에 대해 승인된 최초이자 유일한 치료제가 됨.

Related Recent Events

View Full Timeline